Alcon annual working capital
2008
2009
2010
2018
2019
2020
2021
2022
2023
2024
2025
Alcon Working Capital Growth & History (ALC)
Alcon's working capital was $3.40B for fiscal 2025.
View full Alcon company overviewAlcon annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.40B | −$631.0M | −15.65% |
| 2024 | 2024-12-31 | $4.03B | $782.0M | +24.07% |
| 2023 | 2023-12-31 | $3.25B | $794.0M | +32.34% |
| 2022 | 2022-12-31 | $2.46B | −$459.0M | −15.75% |
| 2021 | 2021-12-31 | $2.91B | $185.0M | +6.78% |
| 2020 | 2020-12-31 | $2.73B | $793.0M | +40.96% |
| 2019 | 2019-12-31 | $1.94B | $430.0M | +28.55% |
| 2018 | 2018-12-31 | $1.51B | — | — |
| 2010 | 2010-12-31 | $4.28B | $420.0M | +10.89% |
| 2009 | 2009-12-31 | $3.86B | $829.0M | +27.37% |
| 2008 | 2008-12-31 | $3.03B | — | — |
Alcon quarterly working capital
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.46B | −$425.0M | −10.95% |
| Q1 2026 | 2026-03-31 | $3.62B | −$205.0M | −5.37% |
| Q4 2025 | 2025-12-31 | $3.40B | −$631.0M | −15.65% |
| Q3 2025 | 2025-09-30 | $3.34B | — | — |
| Q2 2025 | 2025-06-30 | $3.88B | $235.0M | +6.44% |
| Q1 2025 | 2025-03-31 | $3.82B | — | — |
| Q4 2024 | 2024-12-31 | $4.03B | $782.0M | +24.07% |
| Q2 2024 | 2024-06-30 | $3.65B | $853.0M | +30.53% |
| Q4 2023 | 2023-12-31 | $3.25B | $794.0M | +32.34% |
| Q2 2023 | 2023-06-30 | $2.79B | $97.0M | +3.60% |
| Q4 2022 | 2022-12-31 | $2.46B | −$459.0M | −15.75% |
| Q2 2022 | 2022-06-30 | $2.70B | −$121.0M | −4.29% |
| Q4 2021 | 2021-12-31 | $2.91B | $185.0M | +6.78% |
| Q2 2021 | 2021-06-30 | $2.82B | $264.0M | +10.34% |
| Q4 2020 | 2020-12-31 | $2.73B | $793.0M | +40.96% |
| Q2 2020 | 2020-06-30 | $2.55B | $2.23B | +688.27% |
| Q4 2019 | 2019-12-31 | $1.94B | $430.0M | +28.55% |
| Q2 2019 | 2019-06-30 | $324.0M | — | — |
| Q4 2018 | 2018-12-31 | $1.51B | — | — |
| Q4 2010 | 2010-12-31 | $4.28B | $420.0M | +10.89% |
| Q3 2010 | 2010-09-30 | $3.87B | $544.0M | +16.38% |
| Q2 2010 | 2010-06-30 | $3.55B | $605.0M | +20.54% |
| Q1 2010 | 2010-03-31 | $4.18B | — | — |
| Q4 2009 | 2009-12-31 | $3.86B | $829.0M | +27.37% |
| Q3 2009 | 2009-09-30 | $3.32B | — | — |
| Q2 2009 | 2009-06-30 | $2.95B | — | — |
| Q4 2008 | 2008-12-31 | $3.03B | — | — |
Alcon working capital trends
Over the last five fiscal years, Alcon's working capital increased from $2.73B to $3.40B, a change of $671.0M. The latest reported quarter, Q2 2026, shows $3.46B.
About the metric
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
Calculation and source
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alcon source filings ↗Community posts
Alcon completes $550 million Neurotech acquisition to enter MacTel treatment
Alcon ($ALC) has acquired Neurotech for $550 million, with additional payments dependent on commercial milestones. The transaction adds ENCELTO, a cell-based ocular therapy for adults with macular telangiectasia type 2. The product received ...
